Company: CMND
Filing Date: 2025-11-26
Form Type: F-1
Source: 0001213900-25-115501
Chunk: 0

Company: Clearmind Medicine Inc.
Filing Date: 2025-11-26
Form: F-1
Chunk 0
---
<div align='center'>As filed with the Securities and Exchange Commission on November 26, 2025.</div>

Registration No. 333-

<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM F-1

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

Clearmind Medicine Inc.(Exact name of registrant as specified in its charter)</div>

| British Columbia                |     |                         2834 |     | Not Applicable        |
| (State or other jurisdiction of 
 incorporation or organization)  |     | -Primary Standard Industrial 
   Classification Code Number |     | -I.R.S. Employer      
 Identification Number |

| 101 – 1220 West 6th Avenue                                        
 Vancouver, British Columbia V6H1A5                                
 Tel: 973.536.1016                                                 |     | Puglisi & Associates                      
 850 Library Ave., Suite 204               
 Newark, DE 19711                          
 Tel: (302) 738-6680                       |
| (Address, including zip code, and telephone number,               
 including area code, of registrant’s principal executive offices) |     | -Name, address,                           
 including zip code, and telephone number, 
 including area code, of agent for service |

<div align='center'>Copies to:</div>

| David Huberman, Esq.           
 Greenberg Traurig, P.A.        
 One Azrieli Center             
 Round Tower, 30th floor        
 132 Menachem Begin Rd          
 Tel Aviv 6701101               
 Telephone: +972 (0) 3.636.6000 |     | Daniel N. Bloch          
 414-100 Richmond St. W.  
 Toronto, Ontario M5H 3K6 
 Telephone: 416.722.0804  |

Approximate date of commencement of proposed sale to the public: As
soon as practicable after the effective date hereof.

If any of the securities being registered on this form are to be offered
on a delayed or continuous basis pursuant to Rule 415 under the Securities Act, check the following box. ☒

If this form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number
of the earlier effective registration statement for the same offering. ☐

If this form is a post